FIGHTING BACK IN THE COURTS AND STATE CAPITOLS Litigation and Legislative Trends in the US.
-
Upload
arthur-mckinney -
Category
Documents
-
view
215 -
download
0
Transcript of FIGHTING BACK IN THE COURTS AND STATE CAPITOLS Litigation and Legislative Trends in the US.
FIGHTING BACK IN THE COURTS AND STATE CAPITOLS
Litigation and Legislative Trends in the US
Overview
Legislative Explosion
Abortion Restrictions Enacted By Year
2011: 92 restrictions
1985 1990 1995 2000 2005 2010
2012: 43 restrictions
2013: 68 restrictions
Legislative Explosion
Abortion Restrictions Enacted By Year
2011: 92 restrictions
1985 1990 1995 2000 2005 2010
2012: 43 restrictions
2013: 68 restrictions
Legislative Explosion: 2013
Overview
Targeted Regulations
Intense, Targeted Regulation: 2012
AZKSLAOKSDWI
44 Other States
19 restriction
s
24 restriction
s
Intense, Targeted Regulation: Texas
2003: Abortions past 15 weeks LMP must be performed in an Ambulatory Surgery Center
2005: Third-trimester abortions banned
2003: Women must submit to a 24 hour waiting period
2005: Minors must get written parental consent
2005: State funding rerouted from family planning to crisis pregnancy centers
2010: Planned Parenthood affiliates are defunded, even those that do not perform abortions
2011: Mandatory ultrasounds
2013: All abortions after 22 weeks LMP banned
2013: All doctors performing abortions must have admitting privileges at a hospital within 30 miles of the clinic
2013: Medication abortion restricted to “on-label” regimen
2014: All abortions must be performed in ambulatory surgery centers
End Result: Two Providers Left for 60,000 women
Restrictions on Medication Abortion
Restrictions on Medication Abortion
1996: FDA application -Trials of <3000 women -600 mg mifepristone/400 µg misoprostol (oral) -49 days LMP
1996-2006: Additional clinical trials and use after approval -Studies & trials of 100,000s of women -200 mg mifepristone/800 µg misoprostol (vaginal) -63 days LMP
2000: Approval of original application -FPL based on 1996-era research
2006-2013: Most common current regimen -Studies of 200,000+ women -200 mg mifepristone/800 µg misoprostol (buccal) -63 days LMP
Final Printed Label
Restrictions on Medication AbortionFinal Printed Label
FPL law in effectFPL law enjoined
Restrictions on Medication Abortion
Local Admitting Privileges
Local Admitting Privileges
Local Admitting Privileges
“20-Week” Bans
“20-Week” Bans
“20-Week” Bans
Conclusion